Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NasalCEASE and BleedCEASE

K-Number: K183622 · 2019-12-02

Decision Date2019-12-02
Product CodeQSY
DecisionSubstantially Equivalent

Device Summary

NasalCEASE and BleedCEASE is the device name listed in this FDA 510(k) record. The listed applicant is Les Laboratoires Brothier S.A.. It received FDA 510(k) clearance on 2019-12-02 under 510(k) number K183622. The device is classified under product code QSY. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NasalCEASE and BleedCEASE?

NasalCEASE and BleedCEASE is a medical device that received FDA 510(k) clearance on 2019-12-02. The listed applicant is Les Laboratoires Brothier S.A.. The 510(k) number is K183622.

When did NasalCEASE and BleedCEASE receive FDA 510(k) clearance?

NasalCEASE and BleedCEASE received FDA 510(k) clearance on 2019-12-02, under 510(k) number K183622.

Who is the listed applicant for NasalCEASE and BleedCEASE?

The FDA 510(k) record lists Les Laboratoires Brothier S.A. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for NasalCEASE and BleedCEASE?

The FDA product code for NasalCEASE and BleedCEASE is QSY.

Related Devices (Code: QSY)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.